We are live on ! Find out more
RAPT

RAPT Therapeutics
RAPT

Delisted

RAPT was delisted on the 2nd of March, 2026.

Back to rankings

99 hedge funds and large institutions have $1.02B invested in RAPT Therapeutics in 2021 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 28 increasing their positions, 34 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,497% more call options, than puts

Call options by funds: $12.9M | Put options by funds: $495K

25% more capital invested

Capital invested by funds: $815M → $1.02B (+$205M)

11% more funds holding in top 10

Funds holding in top 10: 9 → 10 (+1)

0.59% more ownership

Funds ownership: 11.19% → 11.78% (+0.59%)

7% less funds holding

Funds holding: 106 → 99 (-7)

18% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 34

19% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 21

Holders
99
Holders Change
-7
Holders Change %
-6.6%
% of All Funds
1.52%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.15%
New
17
Increased
28
Reduced
34
Closed
21
Calls
$12.9M
Puts
$495K
Net Calls
+$12.4M
Net Calls Change
+$9.69M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$37M
2
State Street
State Street
Massachusetts
+$30M
3
Deutsche Bank
Deutsche Bank
Germany
+$9.92M
4
Morgan Stanley
Morgan Stanley
New York
+$7.89M
5
O
OrbiMed
New York
+$7.25M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$15.6M
2
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$8.94M
3
EC
Euclidean Capital
New York
-$6.76M
4
ROTUOC
Regents of the University of California
California
-$5.51M
5
SG Americas Securities
SG Americas Securities
New York
-$5.22M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$5.22M +$64.7K +242 +1%
Two Sigma Investments
27
Two Sigma Investments
New York
$5.05M -$2.47M -9,227 -35%
SSA
28
Schonfeld Strategic Advisors
New York
$4.89M -$2.11M -7,907 -32%
PCM
29
Pentwater Capital Management
Florida
$4.22M – – –
VOYA Investment Management
30
VOYA Investment Management
Georgia
$4.15M -$16.6K -62 -0.4%
VCIM
31
Velan Capital Investment Management
Georgia
$4.04M +$3.68M +13,750 New
Marshall Wace
32
Marshall Wace
United Kingdom
$4.02M -$355K -1,328 -9%
TD Asset Management
33
TD Asset Management
Ontario, Canada
$3.99M +$832K +3,113 +30%
AIIC
34
AJU IB Investment Company
South Korea
$3.65M – – –
Norges Bank
35
Norges Bank
Norway
$3.62M -$4.75M -17,763 -59%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$3.09M +$2.81M +10,517 New
Bank of America
37
Bank of America
North Carolina
$3.02M +$2.44M +9,138 +801%
AIMCA
38
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.94M +$2.67M +10,000 New
UBS Group
39
UBS Group
Switzerland
$2.87M +$2.4M +8,985 +1,153%
N
40
Nuveen
North Carolina
$2.7M -$521K -1,950 -10%
Citigroup
41
Citigroup
New York
$2.52M +$2.15M +8,053 +1,500%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$2.52M -$1.98M -7,390 -46%
Bank of New York Mellon
43
Bank of New York Mellon
New York
$2.42M -$627K -2,345 -22%
JGC
44
J. Goldman & Co
New York
$1.88M +$1.71M +6,382 New
Walleye Capital
45
Walleye Capital
New York
$1.87M -$1.35M -5,037 -44%
TLP
46
Tri Locum Partners
New York
$1.77M +$1.61M +6,018 New
JRP
47
Jasper Ridge Partners
California
$1.68M – – –
Swiss National Bank
48
Swiss National Bank
Switzerland
$1.55M +$29.9K +112 +2%
Susquehanna International Group
49
Susquehanna International Group
Pennsylvania
$1.43M +$1.3M +4,857 New
Goldman Sachs
50
Goldman Sachs
New York
$1.33M +$157K +588 +15%
1
2
3 4 5

RAPT Hedge Fund Activity: Q4 2021 in Review

99 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2021, worth a combined $1.02B — up 25% from $815M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of RAPT and 17 opened new positions — a net loss of 4 holders — while 34 trimmed existing stakes and 28 added.

The largest buyer was Fidelity Investments, adding an estimated $37M. The largest seller was Millennium Management, cutting an estimated $15.6M.

  • 99 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2021, down from 106 in Q3 2021.
  • Funds reported $1.02B of RAPT Therapeutics stock for Q4 2021, up 25% quarter-over-quarter.
  • 17 funds opened new RAPT Therapeutics positions in Q4 2021 and 21 closed out, a net change of -4 holders.
  • The largest RAPT Therapeutics buyer in Q4 2021 was Fidelity Investments, an estimated $37M added.
  • The largest RAPT Therapeutics seller in Q4 2021 was Millennium Management, an estimated $15.6M sold.

Based on aggregated 13F filings for Q4 2021.